GM Chertow, P Vart, N Jongs, RD Toto… - Journal of the …, 2021 - journals.lww.com
… trial, we show beneficial effects of dapagliflozin on kidney and … loss of kidney function as reflected by the eGFR slopes over time. … developed kidney failure requiring dialysis or kidney …
JJV McMurray, DC Wheeler, BV Stefánsson, N Jongs… - Circulation, 2021 - Am Heart Assoc
… effects of dapagliflozin on the prespecified kidney and cardiovascular outcomes in patients with chronic kidneydisease … of cardiovascular disease, in the DAPA-CKD trial (Dapagliflozin …
JJV McMurray, DC Wheeler, BV Stefánsson, N Jongs… - Heart Failure, 2021 - jacc.org
… investigate the effects of dapagliflozin in chronic kidneydisease (… kidney-specific composite of sustained decline in eGFR of at least 50%, end-stage kidneydisease, or death from kidney …
DC Wheeler, BV Stefánsson, N Jongs… - The lancet Diabetes & …, 2021 - thelancet.com
… with chronic kidneydisease. We aimed to investigate the effects of dapagliflozin on kidney, … according to underlying cause of chronic kidneydisease, reported as diabetic nephropathy, …
… Thereby, our results show the effect of an SGLT2 inhibitor on both early … chronic kidney disease in patients with type 2 diabetes. DECLARE–TIMI 58 is the first study to show the effects of …
HJL Heerspink, N Jongs, GM Chertow… - The lancet Diabetes & …, 2021 - thelancet.com
… the effect of dapagliflozin by the underlying cause of chronic kidneydisease, treatment with dapagliflozin … than did placebo across different chronic kidneydisease aetiologies (figure 2). …
… kidneyeffects of the SGLT2 inhibitor dapagliflozin in patients with proteinuric kidneydisease … on clinical kidney outcomes in patients with chronic kidneydisease with and without …
N Jongs, T Greene, GM Chertow… - The lancet Diabetes & …, 2021 - thelancet.com
… Whether this effect persists in patients with chronic kidneydisease with and without type 2 … the effects of dapagliflozin on albuminuria in patients with chronic kidneydisease with and …
CCJ Dekkers, DC Wheeler, CD Sjöström… - Nephrology dialysis …, 2018 - academic.oup.com
… We characterized the effects of dapagliflozin 5 mg/day or dapagliflozin 10 mg/day versus placebo on HbA1c, markers of kidney function [eGFR, urinary albumin:creatinine ratio (UACR), …